Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
•
Thoracic Surgery
How do you decide which local consolidative therapy to offer for a single lung metastasis in a patient with metastatic colorectal cancer?
(ie. surgery vs SBRT)
Answer from: Radiation Oncologist at Community Practice
SBRT, then more chemotherapy.
Sign In
or
Register
to read more
6461
Related Questions
In resected N2 NSCLC, what nodal pathologic characteristics prompt you to recommend PORT?
Is there a concern for using FFF beams in single isocenter multi target lung SBRT?
How does metaplastic thymoma histology impact your decision regarding adjuvant radiation?
Do more fractionated regimens reduce severe toxicity over SBRT in patients with ILD and early-stage NSCLC?
Would you offer empiric lung SBRT for two growing FDG-avid lung lesions in a patient with severe COPD on oxygen?
Would you offer SBRT for primary pulmonary adenoid cystic carcinoma in a patient who was medically not a surgical candidate?
Do you restrict the dose rate during treatment delivery to a pacemaker in addition to limiting the Dmax?
Do you recommend consolidation immunotherapy after SBRT or surgery and chemo for T1-T2N0 SCLC?
Would you treat a patient with an N2 ipsilateral recurrence following re-resection of bronchial stump recurrence?
What are your top takeaways in thoracic cancers from ESMO 2025?